| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Revenue  | 963 | 1,017 | 722 | 873 | 1,425 | 1,027 | 1,128 | 1,248 | 1,167 | 934 |
| Expenses | 856 | 877 | 621 | 701 | 1,041 | 763 | 847 | 905 | 845 | 616 |
| EBITDA | 107 | 140 | 101 | 173 | 384 | 264 | 281 | 343 | 322 | 318 |
| Operating Profit % | 9 % | 12 % | 11 % | 17 % | 23 % | 24 % | 24 % | 26 % | 27 % | 34 % |
| Depreciation | 23 | 25 | 19 | 21 | 30 | 30 | 27 | 28 | 27 | 17 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
| Profit Before Tax | 83 | 115 | 99 | 158 | 355 | 233 | 253 | 314 | 273 | 312 |
| Tax | 30 | 36 | 38 | 56 | 101 | 57 | 61 | 85 | 72 | 78 |
| Net Profit | 54 | 79 | 61 | 102 | 254 | 177 | 193 | 230 | 201 | 234 |
| EPS in ₹ | 32.30 | 47.70 | 56.60 | 505.27 | 153.00 | 107.00 | 116.00 | 138.00 | 121.00 | 141.22 |
Procter & Gamble Health
5,755.50
+78.00
(1.37%)
Market Cap
9,424.30 Cr
EPS
141.22
PE Ratio
36.87
Dividend Yield
4.50 %
Industry
Healthcare52 Week High
6,175.50
52 Week Low
4,863.00
PB Ratio
17.86
Debt to Equity
0.02
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,672.00 | #1 3,98,889.40 | 35.03 | #1 54,729.00 | 12.06 | #1 10,980 | -18.99 | 47.52 | |
6,835.00 | 1,81,700.00 | 82.80 | 9,360.00 | 0.89 | 2,117 | 23.05 | 58.12 | |
1,485.00 | 1,19,363.10 | 23.31 | 28,409.50 | 7.12 | 5,291 | 30.28 | 45.00 | |
3,314.20 | 1,13,020.50 | 58.54 | 11,539.40 | 11.59 | 1,911 | 10.91 | 53.58 | |
1,254.70 | 1,05,372.90 | #1 18.86 | 33,741.20 | 12.36 | 5,725 | 21.14 | 39.63 | |
2,578.30 | 1,04,998.20 | 53.56 | 12,207.40 | 19.57 | 1,925 | -10.91 | 70.20 | |
979.60 | 97,901.50 | 21.11 | 22,573.80 | 13.82 | 3,977 | -0.19 | 55.12 | |
1,894.70 | 86,534.70 | 26.34 | 22,192.10 | #1 19.94 | 3,024 | #1 112.49 | 36.85 | |
34,420.00 | 73,427.00 | 51.70 | 6,409.15 | 10.80 | 1,417 | 27.83 | 60.71 | |
1,124.80 | 65,624.80 | 18.90 | 31,378.10 | 17.55 | 3,366 | -0.50 | 44.29 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
-6.50 %
Net Income Growth
-12.42 %
Cash Flow Change
-3.28 %
ROE
22.19 %
ROCE
20.53 %
EBITDA Margin (Avg.)
0.25 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 784 | 879 | 991 | 1,760 | 1,176 | 986 | 888 | 1,101 | 794 |
| Fixed Assets | 132 | 111 | 115 | 104 | 101 | 104 | 112 | 144 | 129 |
| Current Assets | 572 | 636 | 752 | 1,534 | 954 | 727 | 608 | 796 | 524 |
| Capital Work in Progress | 7 | 30 | 9 | 17 | 22 | 39 | 41 | 33 | 6 |
| Investments | 42 | 28 | 70 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 603 | 711 | 797 | 1,639 | 1,053 | 843 | 736 | 925 | 660 |
| Total Liabilities | 784 | 879 | 991 | 1,760 | 1,176 | 986 | 888 | 1,101 | 794 |
| Current Liabilities | 165 | 186 | 225 | 193 | 227 | 239 | 232 | 304 | 219 |
| Non Current Liabilities | 27 | 29 | 33 | 27 | 42 | 44 | 40 | 46 | 37 |
| Total Equity | 592 | 664 | 733 | 1,540 | 906 | 704 | 617 | 751 | 538 |
| Reserve & Surplus | 575 | 647 | 717 | 1,524 | 890 | 687 | 600 | 734 | 522 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 4 | 17 | -16 | 1,109 | -483 | -172 | -145 | 116 | -197 |
| Investing Activities | -68 | -75 | -48 | 1,270 | 165 | -32 | -26 | -22 | -7 |
| Operating Activities | 84 | 107 | 54 | -130 | 235 | 247 | 170 | 236 | 228 |
| Financing Activities | -12 | -15 | -22 | -30 | -883 | -387 | -289 | -99 | -418 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 7.59 % | 6.24 % | 6.40 % | 6.61 % | 7.02 % | 6.87 % |
| DIIs | 11.48 % | 11.81 % | 8.37 % | 8.53 % | 7.90 % | 8.07 % | 12.62 % | 12.43 % | 12.31 % | 12.30 % | 12.13 % | 12.67 % | 13.73 % | 14.55 % | 14.84 % | 14.71 % | 14.21 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 24.58 % | 24.49 % | 24.80 % | 24.55 % | 24.81 % | 25.09 % | 24.46 % | 24.33 % | 24.09 % | 23.64 % | 23.43 % | 22.91 % | 22.61 % | 21.82 % | 21.46 % | 21.34 % | 21.90 % |
| Others | 12.13 % | 11.88 % | 15.01 % | 15.10 % | 15.47 % | 15.02 % | 11.11 % | 11.43 % | 11.78 % | 12.25 % | 12.62 % | 5.02 % | 5.60 % | 5.41 % | 5.28 % | 5.12 % | 5.21 % |
| No of Share Holders | 0 | 53,075 | 58,818 | 63,525 | 65,537 | 66,289 | 65,729 | 65,148 | 61,030 | 58,856 | 57,919 | 56,730 | 56,778 | 55,923 | 54,792 | 53,736 | 53,993 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 11 | 15 | 440 | 0.00 | 230 | 130 | 52.5 | 95 | 260 | 0.00 |
| Dividend Yield (%) | 1.05 | 1 | 11.91 | 0.00 | 3.71 | 3.25 | 1.12 | 2.02 | 5.05 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Aug 2025 |  Quarterly Result Announcement | NA | 01 Aug 2025 | 5,876.30 | 5,755.50 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 5,410.00 | 5,729.50 |
| 21 Feb 2025 |  Dividend | ₹ 80.00 /share | 21 Feb 2025 | 5,259.70 | 5,345.60 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 5,446.35 | 5,259.70 |
| 05 Dec 2024 |  Annual General Meeting | NA | 05 Dec 2024 | 5,373.45 | 5,346.85 |
| 29 Nov 2024 | Dividend | ₹ 60.00 /share | 28 Nov 2024 | 5,422.90 | 5,168.55 |
| 04 Nov 2024 | Quarterly Result Announcement | NA | 04 Nov 2024 | 5,251.05 | 5,196.40 |
| 14 Feb 2024 | Dividend | ₹ 150.00 /share | 14 Feb 2024 | 5,136.60 | 5,503.95 |
| 14 Feb 2024 | Dividend | ₹ 50.00 /share | 14 Feb 2024 | 5,136.60 | 5,503.95 |
| 30 Nov 2023 | Annual General Meeting | NA | 30 Nov 2023 | 5,343.35 | 5,154.75 |
| 24 Nov 2023 | Dividend | ₹ 50.00 /share | 23 Nov 2023 | 5,360.10 | 5,072.15 |
| 13 Feb 2023 | Dividend | ₹ 45.00 /share | 13 Feb 2023 | 4,096.95 | 4,702.90 |
| 23 Nov 2022 | Annual General Meeting | NA | 23 Nov 2022 | 4,279.25 | 4,163.45 |
| 17 Nov 2022 | Dividend | ₹ 11.50 /share | 15 Nov 2022 | 4,190.70 | 4,290.60 |
| 13 May 2022 | Dividend | ₹ 41.00 /share | 12 May 2022 | 4,409.35 | 4,294.00 |
| 05 Nov 2021 | Dividend | ₹ 90.00 /share | 02 Nov 2021 | 5,374.30 | 5,444.20 |
| 05 Nov 2021 | Dividend | ₹ 40.00 /share | 02 Nov 2021 | 5,424.55 | 5,444.20 |
| 06 May 2019 |  Change Of Name | NA | 06 May 2019 | 3,672.50 | 3,672.50 |
Announcements
Announcement under Regulation 30 (LODR)-Change in Management
Jun 27, 2025
Jun 27, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On August 1 2025Jun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 17, 2025
Jun 17, 2025Analysts/Institutional Investors - PresentationJun 16, 2025
Jun 16, 2025Change In Senior Management Personnel Of The Company
Jun 11, 2025
Jun 11, 2025Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health LimitedJun 09, 2025
Jun 09, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2025
May 29, 2025Appointment Of Secretarial AuditorsMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2025
May 29, 2025Corporate Action-Board approves DividendMay 29, 2025
May 29, 2025Financial Results For The Year Ended March 312025May 29, 2025
May 29, 2025Board Meeting Outcome for Outcome On Financial Results And DividendMay 29, 2025
May 29, 2025Board Meeting Outcome for Outcome On Financial Results And DividendMay 29, 2025
May 29, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Apr 14, 2025Appointment Of Mr. Sharad Tyagi (DIN- 00371842) And Ms. Krishna Sarma (DIN00016115) As Non-Executive Independent Directors Of The Company For A Period Of Five
YearsApr 10, 2025
Apr 10, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 10, 2025
Apr 10, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On May 29 2025Mar 26, 2025
Mar 26, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 10, 2025
Mar 10, 2025Integrated Filing (Financial)Feb 18, 2025
Feb 18, 2025Communication With Respect To Tds On Dividend Income Declared By The CompanyFeb 13, 2025
Feb 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 12, 2025
Feb 12, 2025Appointment Of Chairperson Of The BoardFeb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 12, 2025
Feb 12, 2025Corporate Action-Board approves DividendFeb 12, 2025
Feb 12, 2025Unaudited Financial ResultsFeb 12, 2025
Feb 12, 2025Board Meeting Outcome for Unaudited Financial Result And Interim Dividend For The FY 2024-25Feb 12, 2025
Feb 12, 2025Board Meeting Outcome for Unaudited Financial Result And Interim Dividend For The FY 2024-25Feb 12, 2025
Feb 12, 2025Update on board meetingJan 31, 2025
Jan 31, 2025Intimation Regarding Change Of The Financial Year Of The CompanyJan 23, 2025
Jan 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Jan 09, 2025Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On February 12 2025Dec 27, 2024
Dec 27, 2024Closure of Trading WindowDec 27, 2024
Dec 27, 2024Change In Senior Management Personnel Of The CompanyDec 06, 2024
Dec 06, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMDec 06, 2024
Dec 06, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportDec 06, 2024
Dec 06, 2024Proceedings Of The 57Th Annual General Meeting Of Shareholders Held On December 5, 2024Dec 05, 2024
Dec 05, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 21, 2024
Nov 21, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 20, 2024
Nov 20, 2024Reg. 34 (1) Annual Report.Nov 13, 2024
Nov 13, 2024Business Responsibility and Sustainability Reporting (BRSR)Nov 13, 2024
Nov 13, 2024Annual Report And Notice Calling The 57Th Annual General Meeting Of The Company For The Financial Year Ended June 30, 2024Nov 13, 2024
Nov 13, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 04, 2024
Nov 04, 2024For The Quarter Ended September 30,2024Nov 04, 2024
Nov 04, 2024Board Meeting Outcome for Unaudited Financial ResultsNov 04, 2024
Nov 04, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 29, 2024
Oct 29, 2024Technical Indicators
RSI(14)
Neutral 50.22
ATR(14)
Volatile 150.71
STOCH(9,6)
Neutral 27.80
STOCH RSI(14)
Oversold 9.55
MACD(12,26)
Bearish -37.09
ADX(14)
Weak Trend 24.84
UO(9)
Bearish 41.33
ROC(12)
Downtrend And Accelerating -2.51
WillR(14)
Neutral -62.12
Mutual Fund Holdings
Nippon India Small Cap Fund Direct- Growth 
UTI Balanced Advantage Fund Direct - Growth 
DSP Healthcare Fund Direct - Growth 
HDFC BSE 500 Index Fund Direct - Growth 
Bandhan BSE Healthcare Index Fund Direct-Growth 
Mirae Asset Nifty Total Market Index Fund Direct-Growth 
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct-Growth 
ICICI Prudential Bharat Consumption Fund Direct - Growth 
Aditya Birla Sun Life MNC Fund Direct-Growth 
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
Sundaram Long Term Tax Advantage Fund Series IV Direct - Growth 
Tata India Pharma & Healthcare Fund Direct-Growth 
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
